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Abstract: Pu-erh tea is a kind of fermented tea with the incorporation of microorganisms’ 
metabolites. Unlike green tea, the chemical characteristics and bioactivities of Pu-erh tea 
are still not well understood. Using water extracts of Pu-erh tea, we analyzed the tumor cell 
growth inhibition activities on several genetically engineered mouse tumor cell lines. We 
found that at the  concentration that did not affect wild type mouse  embryo  fibroblasts 
(MEFs) growth, Pu-erh tea extracts could inhibit tumor cell growth by down-regulated  
S  phase  and  cause  G1  or  G2  arrest.  Further  study  showed  that  Pu-erh  tea  extracts  
down-regulated the expression of mutant p53 in tumor cells at the protein level as well as 
mRNA level. The same concentration of Pu-erh tea solution did not cause p53 stabilization 
or activation of its downstream pathways in wild type cells. We also found that Pu-erh tea 
treatment could slightly down-regulate both HSP70 and HSP90 protein levels in tumor 
cells. These data revealed the action of Pu-erh tea on tumor cells and provided the possible 
mechanism for Pu-erh tea action, which explained its selectivity in inhibiting tumor cells 
without affecting wild type cells. Our data sheds light on the application of Pu-erh tea as an 
anti-tumor agent with low side effects. 
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1. Introduction  
Pu-erh tea is produced in the Yunnan province of China. The key process of Pu-erh preparation 
includes the step of fermentation, in which microorganisms play a very important role in producing the 
taste, color, fragrances, as well as the functional components. This special preparation process makes 
Pu-erh tea unique in terms of its shelf life, as well as its bioactivities. As we know, green tea needs to 
be  consumed  as  fresh  as  possible,  mainly  due  to  the  instability  of  its  anti-oxidant  components. 
However, it is believed in Chinese tradition that the taste, as well as the function of Pu-erh tea gets 
better  with  increasing  shelf  time,  mainly  because  the  fermentation  process  is  still  ongoing  during 
storage. This leads to a very interesting hypothesis, that the bioactivity components of Pu-erh tea are 
produced during the fermentation process. 
Literature  researching  the  chemical  components  and  bioactivities  of  Pu-erh  tea  is  very  limited.  
It has been shown that the Trolox equivalent antioxidant capacity (TEAC) values of the water extracts 
of Pu-erh tea (WEPT) is similar to green tea, oolong tea, and black tea, indicating that WEPT had a 
significant antioxidant activity [1]. However, due to the fermentation  and preservation period,  the 
concentration of total catechins in Pu-erh tea is one tenth of that in green tea suggesting the active 
substances contributing to the antioxidant activity of Pu-erh tea might be formed during fermentation [1]. 
Another  study  also  found  that  Pu-erh  tea  ethyl  acetate  extract  fraction  has  almost  no  monomeric 
polyphenols, theaflavins, and gallic acid, but showed a much stronger antioxidant effect than typical 
green  tea  catechin  (−)-epigallocatechin-3-gallate  [2].  A  very  recent  study  isolated  a  new  amide,  
N-(3,4-dihydroxybenzoyl)-3,4-dihydroxybenzamide  from  the  Pu-erh  tea  and  showed  it  prevented 
H2O2-induced  cell  death  of  human  micro-vascular  endothelial  cell  [3].  However,  it  has  also  
been  shown  by  HPLC-DAD-MS  coupled  with  2,2'-azinobis  (3-ethylbenzthiazolinesulfonic  acid) 
diammonium salt (ABTS) assay that free radical scavengers in Pu-erh tea still attributed to gallic acid, 
(−)-gallocatechin,  (−)-epigallocatechin,  (+)-catechin,  caffeine,  (−)-epicatechin,  (−)-epigallocatechingallate, 
rutin, (−)-epicatechingallate, quercetin-3-glucoside, and kaempferol-3-glucoside. They proposed that 
free  radical  scavenger  activity  in  Pu-erh  raw  tea  was  stronger  than  the  ripe  one,  and  the  activity 
decreased with the increase of preservation [4]. A recent study also showed that the raw Pu-erh tea had 
significantly higher antioxidant activities than the ripened pu-erh teas in the 1,1-diphenyl-2-picrylhydrazyl, 
Trolox equivalent antioxidant capacity. The epigallocatechin-3-gallate, epigallocatechin, epicatechin-3-gallate, 
and quinic acid were decreased and gallic acid was increased in a year-dependent manner [5]. 
In spite of the debates on its anti-oxidant activity, Pu-erh tea has been shown to have anti-obesity 
and anti-tumor activity. An earlier study showed that high molecular weight fractions of green tea, 
black tea, oolong tea, and Pu-erh tea induced apoptosis in human monoblastic leukemia U937 cells as 
well as in stomach cancer MKN-45 cells [6]. It has also been shown that the gains in body weight, 
levels  of  triacylglycerol,  and  total  cholesterol  were  suppressed  in  Pu-erh  tea-treated  rats,  which 
correlated with the down-regulation of fatty acid synthase (FAS) expression in the livers of rats fed 
with tea leaves. In vitro study revealed that FAS expression in hepatoma HepG2 cells was suppressed Int. J. Mol. Sci. 2011, 12  7583 
 
 
by the extracts of Pu-erh tea at both protein and mRNA levels, which might contribute to the cell 
growth inhibition [7]. Further study showed the extract of Pu-erh raw tea with ethyl acetate (PR-3) 
contributed to the most effective hypolipidemic potential and decreased the expression of FAS and 
inhibited the activity of acetyl-coenzyme A carboxylase by stimulating AMP-activated protein kinase. 
Moreover, PR-3-5s blocked the progression of the cell cycle at the G1 phase by inducing p53 and p21  
expression [8]. Our previous study also showed that Pu-erh tea could cause cell cycle arrest of the 
human  gastric  cancer  cell  line  SGC-7901,  but  not  affecting  normal  CCC-HEL-1  cells  [9].  These 
studies suggested that Pu-erh tea has the potential of anti-tumor activity. However, the mechanism and 
the  molecular  targets  of  its  bioactivity  are  still  not  clear.  Due  to  the  unique  procedure  during 
preparation, it is speculated that Pu-erh tea might be different with green tea in terms of its anti-tumor 
action. The understanding of its mechanism in tumor cell growth inhibition will greatly facilitate its 
use in cancer prevention. 
In  this  study,  we  engineered  several  mouse  tumor  cell  lines  by  introducing  either  p53  mutant 
(p53N236S,  p53N239S  in  human)  or/and  Ras  mutant  (H-RasV12)  into  mouse  embryo  fibroblasts 
(MEFs) with p53
−/− genetic background. IARC TP53 database (version R14, November 2009) [10] 
shows that human p53N239S (or p.N239S) has been reported as a somatic mutation in 32 tumor cases, 
tumor origin tissues including breast, colon, stomach, hematopoietic and reticuloendothelial systems, 
liver and intrahepatic bile ducts, bronchus and lung, and brain. The widespread tumor spectrum of 
p53N239S suggested its importance in tumorigenesis. These engineered cell lines are very clear in 
terms of their genetic background and the oncogenic proteins they expressed; thus providing us with 
useful tools in screening and finding the molecular targets of drugs. Because the mutation rates of p53 
and Ras are most frequent in human tumors, these tumor cell lines were used to screen anti-tumor 
activity. Most importantly, we could use the wild type MEFs as a control to test toxicity of drugs. 
By using these cell lines with a clear genetic background, we found that water extracts of Pu-erh tea 
could induce cellular apoptosis in tumor cells but not in control wild type cells. Further study revealed 
that water extracts of Pu-erh tea could reduce the oncogenic mutant p53 level and thus selectively 
eliminate the growth advantages of tumor cells. 
2. Results 
2.1. The Effect of Pu-erh Tea on Wild Type or Tumor Cells 
First, we tried to compare the action of Pu-erh tea on tumor cells with the action of black tea or 
green tea, which have been extensively studied. To our surprise, we found that 0.25 mg/mL of water 
extracts of green tea, black tea or Pu-erh tea have similar activity in inhibiting the growth of tumor 
cells SCID-3B-1 (Figure 1A). As previously reported, the concentration of total catechins in Pu-erh tea 
is one tenth that of green tea [1]. The similar activity of green tea and Pu-erh tea in inhibiting tumor 
cell growth suggested that the tumor cell growth inhibition activity of Pu-erh tea is not due to catechins. Int. J. Mol. Sci. 2011, 12  7584 
 
 
Figure 1. The comparison of tumor cell growth inhibition activity in black tea, green tea, 
and  Pu-erh  tea.  (A)  Tumor  cell  inhibition  after  12  h  treatment  of  0.25  mg/mL  water 
extracts of black tea, green tea, or Pu-erh tea; (B) Tumor cell inhibition after 12 h treatment 
of 0.25 mg/mL water extracts of 3 batches of Pu-erh tea preparation. 
 
Secondly, we tried to understand whether different batches of Pu-erh tea preparations could affect 
the tumor cell growth inhibition activity. For this purpose, we used three different batches of Pu-erh 
tea to treat the tumor cells SCID-3B-1. At the same time, to test whether Pu-erh tea water extracts 
could act on tumor cells selectively, we used wild type (C57/B6) MEFs as a control for non-specific 
cellular toxicity of the treatment. The results showed that different batches of Pu-erh tea had very 
similar activity in tumor cell growth inhibition (Figure 1B, SCID22-3B-1), and the concentration we 
used (0.25 mg/mL) did not inhibit the growth of wild type cells (Figure 1B, wild type). 
With the control of wild type cells, we treated engineered mouse tumor cell lines p53
−/−+Ras and 
p53
−/−+S+Ras with Pu-erh tea solution of a serial of concentrations: 0.1 mg/mL, 0.2 mg/mL, 0.3 mg/mL, 
0.4 mg/mL and 0.5 mg/mL. After 24 h, we were able to observe cell death in tumor cell lines at the 
concentration of 0.2 mg/mL (Figure 2, p53
−/−+Ras and p53
−/−+S+Ras column), while wild type cells 
were  not  obviously  affected  (Figure  2,  wild  type  column).  Robust  cell  death  was  found  at  the 
concentration  of  0.5  mg/mL  (Figure  2,  p53
−/−+Ras  and  p53
−/−+S+Ras  column);  however,  at  this 
concentration cell death was also observed in wild type cells (Figure 2, wild type column). Thus, we 
used 0.2 mg/mL as the working concentration for selectively killing tumor cells. Int. J. Mol. Sci. 2011, 12  7585 
 
 
Figure 2. The effect of Pu-erh tea on wild type or tumor cells. The observation of cell 
morphology change after treating wild type cells or p53
−/−+Ras and p53
−/−+S+Ras tumor 
cells with serial concentration of Pu-erh tea water extracts for 24 h. Compared with no 
treatment control, 0.2 mg/mL Pu-erh tea treatment showed some cell deaths in p53
−/−+S+Ras 
tumor cells, but not in wild type or p53
−/−+Ras tumor cells. The 0.5 mg/mL Pu-erh tea 
treatment induced obvious cell death in p53
−/−+S+Ras and p53
−/−+Ras tumor cells, also 
some in wild type cells. 
 
2.2. Inhibition of Cellular Growth in Several Tumor Cell Lines 
To further test the action of Pu-erh tea water extracts on tumor cell growth, three engineered tumor 
cell lines with different genetic backgrounds were treated with 0.2 mg/mL Pu-erh tea water extracts. 
Due to the presence of chromatophil components in Pu-erh tea extracts, MTT assay was affected and 
was not appropriate for testing the action of Pu-erh tea on cell growth. Thus we used crystal violet 
assay to measure the cell growth curve with or without Pu-erh tea treatment. 
Growth curve assay showed that 0.2 mg/mL Pu-erh tea water extracts could effectively inhibit the 
growth of the SCID22-3B-1 and p53
−/−+S+Ras tumor cells (Figure 3B,D). 0.2 mg/mL Pu-erh tea water 
extracts  could  also  inhibit  cell  growth  of  the  p53
−/−+Ras  tumor  cells,  (Figure  3C),  but  not  as Int. J. Mol. Sci. 2011, 12  7586 
 
 
dramatically as the p53
−/−+S+Ras tumor cells. The same concentration of Pu-erh tea water extracts did 
not affect the growth of the wild type cells (Figure 3A). These results confirmed that 0.2 mg/mL  
Pu-erh tea water extracts could selectively inhibit the growth of tumor cells, but not affect the wild 
type cells. The preference of inhibition on SCID22-3B-1 and p53
−/−+S+Ras tumor cells with mutant 
p53-p53S implied that mutant p53 could be a molecular target of Pu-erh tea action. 
Figure  3.  The  selective  inhibition  of  cellular  growth  in  several  tumor  cell  lines  by  
0.2 mg/mL Pu-erh tea treatment. (A) Growth curve assay showed that wild type cell growth 
was not affected; (B) The growth of tumor cells SCID22-3B-1were inhibited; (C) The growth 
of tumor cells p53
−/−+Ras were affected; (D) The growth of tumor cells p53
−/−+S+Ras  
were inhibited. 
 
2.3. Cellular Response of Tumor Cell Lines to Pu-erh Tea Treatment 
To  further  understand  the  inhibition  of  tumor  cell  growth  by  Pu-erh  tea,  we  performed  flow 
cytometry to analyze the cell cycle regulation in tumor cells after Pu-erh tea treatment. After treating 
with 0.2 mg/mL Pu-erh tea solution for 24 h, the p53
−/−+Ras and p53
−/−+S+Ras tumors cells were 
harvested for flow cytometry analysis. The results showed that in Pu-erh tea treated p53
−/−+Ras cells, Int. J. Mol. Sci. 2011, 12  7587 
 
 
the proportion of cells in S phase was significantly decreased and that in G2 phase was significantly 
increased, suggesting a G2 arrest induced by Pu-erh tea treatment in p53
−/−+Ras cells (Figure 4A). 
Interestingly, in p53
−/−+S+Ras cells, Pu-erh tea caused a significant decrease of cells in S phase and an 
increase of cells in G1 phase, suggesting a G1 arrest (Figure 4B). No obvious apoptosis cell populations 
were observed in both cell lines at this concentration. These results showed the cell cycle arrest effect 
caused by 0.2 mg/mL Pu-erh tea and further confirmed the observation of growth curve assay. 
Figure  4.  Cell  cycle  analysis  of  tumor  cell  lines  at  24  h  after  0.2  mg/mL  Pu-erh  tea 
treatment. (A) Flow cytometry assay of p53
−/−+Ras tumor cells after Pu-erh tea treatment 
showed that the p53
−/−+Ras tumors cells in S phase were reduced, and those in G2 phase 
were increased (p < 0.05); (B) The p53
−/−+S+Ras tumors cells in S phase were reduced, 
and those in G1 phase were increased (p < 0.05). 
 
2.4. Molecular Response to Pu-erh Tea Treatment in Tumor Cell Lines 
To understand the molecular basis of Pu-erh tea action on tumor cell cycle arrest and to test whether 
mutant p53 is the molecular target for Pu-erh tea action, the p53
−/−+S+Ras and p53
−/−+Ras tumor cells 
were treated with 0.2 mg/mL Pu-erh tea water extracts and harvested at different time points to check 
the  molecular  response  to  Pu-erh  tea.  Our  data  showed  that  in  p53
−/−+S+Ras  tumor  cells,  after  
0.2  mg/mL  Pu-erh  tea  water  extracts  treatment,  mutant  p53  protein  level  was  down-regulated  
(Figure 5A, p53). We also observed a slight decrease of HSP70 and HSP90 protein level in response to 
Pu-erh tea treatment (Figure 5A, HSP70, HSP90). These protein regulations, especially the down-
regulation of mutant p53 might contribute to the inhibition of cell growth. In p53
−/−+Ras tumor cells, 
which is null background for p53 and have no mutant p53 expression, we did not observe obvious 
change of HSP70 or HSP90 after Pu-erh tea treatment (Figure 5A). 
To further confirm the Pu-erh tea action on p53S, we used the p53
S/S and p53
S/S+Ras cells which 
express mutant p53S at a level lower than the p53
−/−+S+Ras tumor cells. After treated cells with  
0.2 mg/mL Pu-erh tea water extracts, the p53S protein also decreased in both p53
S/S and p53
S/S+Ras Int. J. Mol. Sci. 2011, 12  7588 
 
 
cells (Figure 5B, p53). HSP70 and HSP90 protein level did not show obvious change in both cells 
(Figure 5B, HSP70, HSP90).  
On  the  other  hand,  our  data  also  showed  that  0.2  mg/mL  Pu-erh  tea  treatment  did  not  
up-regulate the wild type p53 level, suggesting the treatment did not initiate stress response in the wild 
type cells (Figure 5C, p53). Interestingly, the HSP70 and HSP90 protein levels decreased in the wild 
type cells (Figure 5C, HSP70, HSP90). These data further confirmed the selective inhibition effect of 
Pu-erh tea on tumor cells. 
Figure 5. The regulation of p53, HSP70 and HSP90 proteins in tumor cells or wild type 
cells after 0.2 mg/mL Pu-erh tea water extract treatment. (A) The mutant p53 proteins in 
the p53
−/−+S+Ras tumor cells were down-regulated after treatment for 24 h or 36 h, while 
the HSP70 and HSP90 protein levels slightly decreased. In p53
−/−+Ras tumor cells with no 
p53  mutant,  HSP70  and  HSP90  protein  levels  were  not  obviously  changed;  
(B) In p53
S/S and p53
S/S+Ras cells, p53S proteins were also down-regulated but not HSP70 
and HSP90 protein levels; (C) Wild type p53 protein level did not elevate after Pu-erh tea 
treatment  while  HSP70  and  HSP90  protein  levels  were  decreased;  (D)  Real-time  PCR 
showed that p53 mRNA level in p53
−/−+S+Ras tumor cells was down-regulated by Pu-erh 
tea treatment.  
 
We did not observe obvious changes in Bax and Bcl-2 protein levels, suggesting that the apoptosis 
process is not dramatically activated (data not shown). We also did not detect the expression of cell 
cycle regulator p21 protein in these tumor cells even after Pu-erh tea treatment, suggesting that the 
downstream of p53 pathway was not activated in these p53 function deficient cells.  Int. J. Mol. Sci. 2011, 12  7589 
 
 
To understand the regulation of mutant p53 by Pu-erh tea treatment, we performed real-time PCR to 
detect p53 mRNA in p53
−/−+S+Ras cells after Pu-erh tea treatment. We found the mutant p53 mRNA 
level decreased gradually after Pu-erh tea treatment (Figure 5D), which explained the down-regulation 
of mutant p53 revealed by Western blot 5A). Together these data suggest that Pu-erh tea targets the 
p53 mutant and inhibits cell growth. Our data also explained the mechanism for the selective effect of  
Pu-erh tea on tumor cells bearing p53 mutant. 
3. Discussion 
The toxicity of chemotherapeutic drugs has become one of the major issues in chemotherapy. The 
new developments in cancer fields have focused more and more on cancer prevention, early diagnosis 
and  personalized  medicine.  Thus,  chemicals  which  could  target  tumor  specific  molecules  and 
selectively kill tumor cells become one of the most popular topics in drug screening. 
In  this  study,  using  the  wild  type  control  and  genetically  engineered  tumor  cell  lines  as  our 
screening system, we could easily differentiate the toxicity of drug treatment to normal cells from the 
tumor  cell  growth  inhibition  activity.  Furthermore,  the  specific  genetic  background  provided 
advantages in identifying the molecular target of the treatment. 
Green  tea  has  been  reported  extensively  as  anti-tumor  reagents,  which  mainly  attributes  to  its  
anti-oxidant components, such as EGCG, etc., and multiple tumorigenic proteins were found to be 
regulated  by  EGCG  at  different  concentrations.  Among  those,  tumor  promoting  factors  like  DNA 
methyltransferase  (DNMT),  epidermal  growth  factor  receptor  (EGFR),  hepatocyte  growth  factor 
receptor (HGFR), insulin-like growth factor 1 receptor (IGF1R), matrix metalloproteinase (MMP), 
vascular endothelial growth factor A (VEGFA) and BCL-2 are down-regulated by EGCG while tumor 
suppressor p53 is up-regulated [11]. These mechanisms provided the basis for the selective inhibition 
of tumor growth by green tea while not affecting wild type cells. 
Due to its special fermented processing and the incorporation of microbes, Pu-erh tea might be 
different from green tea in terms of its tumor cell growth inhibition activity, as well as its molecular 
targets.  Also,  the  fermentation  by  microbes  might  increase  the  bioavailability  of  Pu-erh  tea 
components. Nevertheless, as a regular drink in human life, we speculated that the toxicity of Pu-erh 
tea  to  normal  cells  should  be  very  limited.  It  has  been  also  reported  that  the  safe  dosage  for  
Sprague-Dawley and Wistar rats could be 5000 mg/kg/day [12,13]. 
In this study, we showed that Pu-erh tea has comparable tumor cell growth inhibition activity with 
black  tea  and  green  tea.  However,  several  independent  groups  have  shown  that  the  fermentation 
process of Pu-erh tea could reduce its total catechins and related anti-oxidant activity [1,4,5]. It is 
reasonable to speculate that the tumor cell growth inhibition activity of Pu-erh tea is due to other 
natural compounds. Further studies are ongoing in finding the natural compound(s) responsible for  
its bioactivity. 
We also found that Pu-erh tea water extracts selectively inhibit tumor cell growth at a concentration 
that does not affect wild type cells. At this concentration, Pu-erh tea water extracts inhibited tumor cell 
growth by down-regulated S phase and caused G1 or G2 arrest. This selective inhibition of tumor cells 
would  greatly  reduce  the  non-specific  cyto-toxicity  and  provide  a  way  of  cancer  prevention  or Int. J. Mol. Sci. 2011, 12  7590 
 
 
treatment that potentially helps to solve the current problem of cyto-toxicity of most conventional 
chemotherapy drugs. 
Furthermore, our studies revealed that Pu-erh tea water extracts down-regulated the expression of 
p53 mutant at both mRNA and protein levels. The down-regulation of mutant p53 by Pu-erh tea might 
eliminate the growth advantage of tumor cells with mutant p53. As we know, more than 50% of human 
tumors have p53 mutation, and mutant p53 proteins could gain oncogenic function and impact tumor 
progression and metastasis [14]. Thus, targeting mutant p53 has become one important strategy in drug 
screening and personalized cancer treatment [15]. Because of its regulation on mutant p53, Pu-erh tea 
has a potential in cancer treatment with low side effects. 
HSP70  and  HSP90  proteins  have  been  targeted  for  cancer  therapy  [16,17]  due  to  their  high 
expression  level  in  tumor  cells  and  their  chaperon  characteristics  for  other  oncogenic  proteins,  
e.g., mutant p53 [18]. Here we also found that Pu-erh tea treatment could slightly down-regulate both 
HSP70 and HSP90 protein levels in tumor cells. However, the down-regulation of HSP70 and HSP90 
by Pu-erh tea seemed to depend on genetic background since we did not observe obvious changes of 
HSP70 and HSP90 in cells with lower p53S or null p53 expression, i.e., p53
S/S cells, p53
S/S +Ras cells 
and p53
−/−+Ras cells. 
On the other hand, our data showed that the same concentration of Pu-erh tea solution did not cause 
p53  stabilization  or  activation  of  its  downstream  pathways  in  the  wild  type  cells.  Growth  curve 
analysis also did not show any growth inhibition of wild type cells by Pu-erh tea treatment. Altogether 
our data revealed the action of Pu-erh tea on tumor cells and provided a possible mechanism for Pu-erh 
tea’s selectivity in inhibiting tumor cells without affecting wild type cells. 
4. Experimental Section  
4.1. Preparation of Pu-erh Tea Water Extracts 
The dry powder form of water extracts of ripe Pu-erh tea was prepared by a standardized protocol. 
Briefly, 10 g ripe Pu-erh tea leaves were boiled in water for 30 min for three times. The supernatant 
was collected, concentrated and spray dried to powder form and stored at 4 °C. The powder was 
resolved in 1 × PBS at 55 °C to make 20 mg/mL stocking solution of Pu-erh tea water extracts. The 
solution was filtered once with filter paper and once with a syringe 0.2 µm filter (Millipore, MA, USA). 
The sterilized Pu-erh tea solution was aliquoted and stored at −20 °C. The black tea and green tea 
water extracts have been made with the same procedure.  
4.2. Cell Lines, Constructs and Antibodies 
Wild type MEFs were harvested and prepared from individual day 13.5 wild type C57/B6 mouse 
embryos. Wild type MEFs were used for experiments before passage 10 and the cells were passed at 
the ratio of 1:2 or 1:3 so that the cells would not be diluted and senesced quickly. 
Immortalized  cell  lines  395-3B-1  harboring  a  p53  point  mutation  (p53S)  were  established  as 
described [19]. 395-3B-1 cells immortalized from MEFs double knocked out telomerase and Werner 
(mTR
−/−Wrn
−/−)  were  injected  subcutaneously  into  SCID  mouse.  The  tumors  growing  from  the 
injected cells were harvested and the tumor cells were cultured to establish SCID22-3B-1 cell line. Int. J. Mol. Sci. 2011, 12  7591 
 
 
Sequencing  of  p53  cDNA  from  these  tumor  cells  revealed  a  p53S  mutation.  Thus  the  genetic 
background of SCID22-3B-1 tumor cell line is mTR
−/−Wrn
−/− p53
S/S.  
pBabe-H-RasV12  construct  and  either  empty  vector  PQCXIH  or  PQCXIH-p53S  construct  (as 
described previously [20]) were introduced into p53
−/− MEF. After 1–2 months antibiotics selection, 
cell colonies were picked up, expression of p53S or H-RasV12 was analyzed by both Western blot and 
immunostaining. By this way, p53
−/− MEFs stably introduced both p53S and H-RasV12 (p53
−/−+S+Ras 
MEFs), or H-RasV12 and empty PQCXIH vector (p53
−/−+Ras MEFs) were established. MEFs were 
cultured and injected into SCID mice to get p53
−/−+S+Ras and p53
−/−+Ras tumor cells. 
p53
S/S and p53
S/+ MEFs were harvested and prepared from individual day 13.5 embryos from p53
S/+ 
mice.  pBabe-H-RasV12  construct  were  introduced  into  these  cells  to  establish  p53
S/S+Ras  or 
p53
S/++Ras MEFs.  
All cell lines were cultured in DMEM media supplemented with 10% fetal bovine serum (Hyclone, 
CA, USA) in a 3% oxygen and 5% CO2 incubator at 37 °C. 
Antibodies  used  for  Western  blot  were  anti-p16Ink4a  (M-156)  (1:500,  Santa  Cruz,  CA,  USA),  
anti-p21 (F-5) (1:500, Santa Cruz, CA, USA), anti-p53 Ab1(clone PAb240) (1:250, Neomarker, CA, USA), 
anti-phospho-p53  (Ser15)  (1:500,  Cell  Signaling,  MA,  USA),  anti-Hsp70  (1:1000,  Stressgen,  BC, 
Canada), anti-Hsp90 (1:1000, Stressgen, BC, Canada), anti-γ-tubulin (1:5000, Upstate, NY, USA). 
4.3. Growth Curve Assay 
2.5 × 104 cells were seeded per well in 12 well plates, triplicates were prepared for each sample. At 
each time point, cells were fixed for 20 min at room temperature in 10% buffered formalin, and stained 
with 1 mL 0.1% crystal violet for 20 min at room temperature. After washing and drying the plates, 
cells were treated with 2 mL 10% acetic acid and OD of the extracted dye was measured at 595 nm.  
4.4. Real-Time RT-PCR 
RNA was extracted from cells and cDNA was synthesized by reverse transcription. Real-time PCR 
was  performed  using  SYBR-Green  PCR  master  mix  following  the  manufacturer’s  instruction  
(Applied  Biosystems,  CA).  The  primers  used  are  as  following:  p53  (Forward  primer:  
5'-TGATGGAGAGTATTTCACCC-3',  Reverse  primer:  5'-GGGCATCCTTTAACTCTAAG-3').  
β-actin  (Forward  primer:  5'-AGAGGGAAATCGTGCGTGAC-3',  Reverse  primer:  
5'-CAATAGTGATGACCTGGCCGT-3'). 
4.5. Cell Cycle Analysis 
Cell cycle analysis was done by flow cytometry (BD, FACS Vantage SE). Data were analyzed by 
Flowjo. Percentages of cells in G1, S, and G2 were determined using the Dean-Jett-Fox algorithm. 
5. Conclusions 
Our  study  found  that  Pu-erh  tea  extracts  could  inhibit  tumor  cell  growth  by  down-regulating  
S phase and G1 or G2 arrest at a concentration that does not affect wild type cell growth. We showed 
that Pu-erh tea extracts down-regulated the mutant p53. HSP70 and HSP90 were regulated depending Int. J. Mol. Sci. 2011, 12  7592 
 
 
on  the  cellular  genetic  background.  These  data  revealed  the  action  of  Pu-erh  tea  on  tumor  cells, 
providing the possible mechanism for Pu-erh tea action, and suggested the possible application of  
Pu-erh tea in cancer treatment.  
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